What is the most recent earnings date for ADXN stock?
ADDEX THERAPEUTICS LTD (ADXN) last reported earnings on 3/9/2026.
NASDAQ:ADXN • US00654J2069
Past quarterly earnings results for ADDEX THERAPEUTICS LTD (ADXN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in CHF): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | - | - | 49.6K | - | -15.07% | |||
| Q2 2025 | - | - | 36.4K | - | -68.43% | |||
| Q1 2025 | - | - | 71.1K | - | -70.60% | |||
| Q4 2024 | - | - | 398.2K | - | 116.65% | |||
| Q3 2024 | - | - | 58.4K | - | -82.26% | |||
| Q2 2024 | - | - | 115.3K | - | -81.76% | |||
| Q1 2024 | -112.22 | - | - | 241.812K | - | -51.84% | ||
| Q4 2023 | - | - | 183.8K | - | -81.88% | |||
| Q3 2023 | - | - | 329.2K | - | -20.81% | |||
| Q2 2023 | - | - | 632K | - | 46.84% | |||
| Q1 2023 | - | - | 502.1K | - | 105.78% | |||
| Q4 2022 | -20.94 | - | -572.62% | 1.015M | - | -12.46% | ||
| Q3 2022 | -2.12 | - | - | 415.7K | - | -45.14% | ||
| Q2 2022 | -4.46 | - | - | 430.4K | - | -78.42% | ||
| Q1 2022 | -3.77 | - | - | 244K | - | -73.55% | ||
| Q4 2021 | -3.11 | - | - | 1.159M | - | -41.88% | ||
| Q3 2021 | - | - | 757.8K | - | 637.88% | |||
| Q2 2021 | - | - | 1.994M | - | 5.81% | |||
| Q1 2021 | - | - | 922.4K | - | -3.16% | |||
| Q4 2020 | - | - | 1.994M | - | - | |||
| Q3 2020 | - | - | 102.7K | - | - | |||
| Q2 2020 | - | - | 1.885M | - | - | |||
| Q1 2020 | - | - | 952.5K | - | - |
Notes
ADDEX THERAPEUTICS LTD (ADXN) last reported earnings on 3/9/2026.
ADDEX THERAPEUTICS LTD (ADXN) missed EPS estimates and missed revenue estimates in the most recent quarter.